BSE filing, NSE: 360ONE. Summary written from the filing by ALFA Finder's alert engine.
360 One Wam Ltd: key numbers
- Share price
- ₹985.00
- Market cap
- ₹42,245 Cr
- Revenue (annual)
- ₹4,362 Cr
- Net profit (annual)
- ₹1,216 Cr
- P/E (TTM)
- 33.9×Sector 19.8×
- Promoter holding
- 5.88%-0.32% QoQ
- FII holding
- 56.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from 360 One Wam Ltd
All →360 One Wam Regulatory Approval
360 ONE Distribution Services' IFSC branch, a subsidiary of 360 ONE WAM, received an IFSCA Certificate of Registration to act as broker dealer, clearing member, depository participant, research entity and distributor. This is a regulatory licence authorising new activities in the IFSC.
360 One Wam Other Announcement
360 ONE WAM sold 1,200 equity shares worth Rs.12,26,292 on NSE on 23 October 2026 under a PIT disclosure. The seller is a Designated Person, and the holding fell to zero.
- Value
- ₹0.12 Cr
360 One Wam Employee Stock Options
360 ONE WAM LIMITED allotted 4,61,384 equity shares to employees following the exercise of stock options under its ESOP scheme.
360 One Wam Debt & Borrowing: ₹200 Cr
360 ONE WAM redeemed its ₹200 Crore Commercial Paper in full at maturity on 22 October 2026. The entire principal was repaid to investors.
- Value
- ₹200.0 Cr
360 One Wam Convertible Warrants
UBS AG warrants converted into 2.05 crore equity shares at Rs.1,030 each. Balance 75% exercise price of Rs.1,583.85 Crore received by 360 ONE WAM.
- Value
- ₹1,584 Cr
360 One Wam Convertible Warrants
360 ONE WAM allotted 2,05,02,939 shares to UBS AG on warrant conversion at Rs.1,030 each. Consideration: Rs.2,111.80 Crore, giving UBS ~4.8%.
- Value
- ₹2,112 Cr
Other board meeting date announcements
All →Oval Projects Engineering Board Meeting Date
Oval Projects Engineering will hold a board meeting on November 4, 2026 to consider half-year results and a warrant issue. Agenda items are proposed; no amount stated.
Novartis India Board Meeting Date
Evonile Pharma will hold a board meeting on November 4, 2026 to approve the rights issue letter of offer. BSE granted in-principle approval for the rights issue.
CHD Chemicals Board Meeting Date
CHD Chemicals intimated a board meeting on 04 Nov 2026 to consider unaudited half-yearly results for September 2026. Trading window remains closed until 06 Nov 2026.
Max Estates Board Meeting Date
Max Estates Limited has informed exchanges that its board will meet on 4 November 2026 to consider unaudited results for the quarter and half year ended 30 September 2026. The trading window stays closed until 6 November 2026.
GKP Printing & Packaging Board Meeting Date
G.K.P. Printing & Packaging announced a board meeting on 4 November 2026 to approve unaudited results for the quarter ended 30 September 2026. Trading window has been closed for insiders since 1 October 2026.
ADF Foods Board Meeting Date
ADF Foods will hold a board meeting on November 5, 2026 to consider unaudited results for the quarter and half year ended September 30, 2026. The meeting will also consider an interim dividend for FY2026-27.